Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Cash from Investing Activities: 2020-2024

Historic Cash from Investing Activities for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $86.1 million.

  • Tango Therapeutics' Cash from Investing Activities rose 45.77% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.9 million, marking a year-over-year increase of 116.31%. This contributed to the annual value of $86.1 million for FY2024, which is 107.90% up from last year.
  • According to the latest figures from FY2024, Tango Therapeutics' Cash from Investing Activities is $86.1 million, which was up 107.90% from $41.4 million recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' Cash from Investing Activities ranged from a high of $86.1 million in FY2024 and a low of -$183.4 million during FY2021.
  • In the last 3 years, Tango Therapeutics' Cash from Investing Activities had a median value of $41.4 million in 2023 and averaged $51.3 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first decreased by 26.10% in 2021, then soared by 114.39% in 2022.
  • Tango Therapeutics' Cash from Investing Activities (Yearly) stood at -$145.5 million in 2020, then fell by 26.10% to -$183.4 million in 2021, then skyrocketed by 114.39% to $26.4 million in 2022, then skyrocketed by 56.92% to $41.4 million in 2023, then skyrocketed by 107.90% to $86.1 million in 2024.